Search Results

Rafarma Pharmaceuticals - We are pleased to announce that Rapharma and its CEO Raivo Unt have entered into a preliminary agreement with Kelun Lifesciences Ltd, a pharmaceutical company based in Sri Lanka, on 17 November 2023.

ValGenesis, Inc. and Life Science Consulting Pvt. Ltd. have partnered to provide best-in-class digital validation solutions to enhance compliance and quality across life sciences disciplines such as production, quality control and assurance, information technology, and research and development.

Meihua International Medical Technologies Co., Ltd., a reputable manufacturer and provider of Class I, II and III disposable medical devices with operating subsidiaries in China, announced that its board of directors has approved and authorized a share repurchase program of up to $3 million of the Company’s outstanding ordinary shares.

According to the latest research by InsightAce Analytic, the Global Cancer Stem Cells Market is valued at US$ 2.1 Bn in 2023, and it is expected to reach US$ 4.5 Bn by 2031, with a CAGR of 9.7% during the forecast period of 2024-2031.

ValGenesis Inc. and Autocal Solutions Pvt. Ltd. have entered into a strategic partnership to address quality assurance and compliance challenges in the life sciences industry in India.

Meihua International Medical Technologies Co., Ltd., a reputable manufacturer and provider of Class I, II, and III disposable medical devices with operating subsidiaries in China, reported its financial results for the fiscal year ended December 31, 2023.

Aragen Life Sciences, a global research, development, and manufacturing solutions provider, announced that it has signed a definitive agreement to acquire Pune-based Intox Pvt. Ltd.